Recruiting IgA Nephropathy Studies in Palo Alto
About IgA Nephropathy Clinical Trials in Palo Alto
IgA nephropathy is the most common form of glomerulonephritis worldwide, caused by deposits of immunoglobulin A in the kidneys. It can lead to kidney inflammation and progressive kidney damage. Treatment includes blood pressure management, immunosuppression, and newer targeted therapies.
There are currently 1 iga nephropathy clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 24 participants. Research is being sponsored by Alexion Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
IgA Nephropathy Clinical Trials in Palo Alto — FAQ
Are there iga nephropathy clinical trials in Palo Alto?
Yes, there are 1 iga nephropathy clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What iga nephropathy treatments are being tested?
The 1 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for iga nephropathy.
Data updated July 13, 2026 from ClinicalTrials.gov